%0 Journal Article %A Andreas Ebbehoj %A Mette Thunbo %A Ole Emil Andersen %A Michala Vilstrup Glindtvad %A Adam Hulman %T Transfer learning for non-image data in clinical research: a scoping review %D 2021 %R 10.1101/2021.10.01.21264290 %J medRxiv %P 2021.10.01.21264290 %X Background Transfer learning is a form of machine learning where a pre-trained model trained on a specific task is reused as a starting point and tailored to another task in a different dataset. While transfer learning has garnered considerable attention in medical image analysis, its use for clinical non-image data is not well studied. Therefore, the objective of this scoping review was to explore the use of transfer learning for non-image data in the clinical literature.Methods and Findings We systematically searched medical databases (PubMed, EMBASE, CINAHL) for peer-reviewed clinical studies that used transfer learning on human non-image data. We included 83 studies in the review. More than half of the studies (63%) were published within 12 months of the search. Transfer learning was most often applied to time series data (61%), followed by tabular data (18%), audio (12%) and text (8%). Thirty-three (40%) studies applied an image-based model to non-image data after transforming data into images (e.g. spectrograms). Twenty-nine (35%) studies did not have any authors with a health-related affiliation. Many studies used publicly available datasets (66%) and models (49%), but fewer shared their code (27%).Conclusions In this scoping review, we have described current trends in the use of transfer learning for non-image data in the clinical literature. We found that the use of transfer learning has grown rapidly within the last few years. We have identified studies and demonstrated the potential of transfer learning in clinical research in a wide range of medical specialties. More interdisciplinary collaborations and the wider adaption of reproducible research principles are needed to increase the impact of transfer learning in clinical research.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AClinical Protocols https://doi.org/10.6084/m9.figshare.14638914.v1 Funding StatementOEA, MGV and AH are employed at Steno Diabetes Center Aarhus that is partly funded by a donation from the Novo Nordisk Foundation. AE and MT are supported by PhD scholarships from Aarhus University. None of the founding bodies had any role in the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data extracted from the identified articles and then presented in the Results section is available as an electronic supplement along with the code used for the data analysis. %U https://www.medrxiv.org/content/medrxiv/early/2021/10/03/2021.10.01.21264290.full.pdf